Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.7100
+0.0100 (1.43%)
Oct 1, 2025, 10:29 AM EDT
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 38.36 million as of October 1, 2025. Its market cap has increased by 20.45% in one year.
Market Cap
38.36M
Enterprise Value
36.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.71
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 38.36M, an increase of 174.87%. That is a compound annual growth rate of 33.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 38.36M | 38.93% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.41B |
| Green Thumb Industries | 2.72B |
| Trulieve Cannabis | 2.29B |
| dentalcorp Holdings | 2.16B |
| Sienna Senior Living | 1.74B |
| Cronos Group | 1.58B |
| WELL Health Technologies | 1.31B |
| Extendicare | 1.27B |